Psoriatic Arthritis An Issue Of Rheumatic Disease Clinics

Some people with psoriasis can also develop psoriatic arthritis, when the immune system attacks the joints as well, causing inflammation. Like psoriasis, psoriatic arthritis symptoms flare and subside, vary from person to person, and even change locations in the same person over time. Psoriatic arthritis can affect any joint in the body, and it may affect just one joint, several joints or multiple joints. For example, it may affect one or both knees. This issue will include articles on Genetic and Epigenetic aspects of psoriatic arthritis, Clinical features and diagnostic considerations in psoriatic arthritis, Natural history, prognosis and socioeconomic aspects of psoriatic arthritis, Etiology and pathogenesis of psoriasis and many more!

Some people with psoriasis can also develop psoriatic arthritis, when the immune system attacks the joints as well, causing inflammation. Like psoriasis, psoriatic arthritis symptoms flare and subside, vary from person to person, and even change locations in the same person over time. Psoriatic arthritis can affect any joint in the body, and it may affect just one joint, several joints or multiple joints. For example, it may affect one or both knees. This issue will include articles on Genetic and Epigenetic aspects of psoriatic arthritis, Clinical features and diagnostic considerations in psoriatic arthritis, Natural history, prognosis and socioeconomic aspects of psoriatic arthritis, Etiology and pathogenesis of psoriasis and many more!

Guest edited by Drs. Jonathan Kay and Sergio Schwartzman, this issue of Rheumatic Disease Clinics will cover Controversies in Rheumatology. This issue is one of four selected each year by our series Consulting Editor, Dr. Michael Weisman of Cedars-Sinai. Articles explore several questions, including, but not limited to: Is triple therapy or methotrexate plus a biologic the initial treatment of choice for RA patients; Is hypo or hyper-uricemia a risk requiring treatment for cardiac morbidity and mortality; Are there benefits and risks to biosimilars from a patient perspective; Should platelet-rich plasma be used to treat osteoarthritis; Is there a role for stem cell therapy to treat cartilage defects in osteoarthritis; Should any rheumatology patient, today, be treated with bone marrow ablation and stem cell transplantation; Is there effective prevention, prophylaxis, or treatment for CPPD arthritis; Is fibromyalgia a psychiatric disease or a pain syndrome; Should cyclophosphamide still be used to treat ANCA-associated vasculitis; Does methotrexate have a place in the treatment of psoriatic arthritis; Should hydroxychloroquine dosing be limited because of potential ocular toxicity; and Should generalized immunosuppression or targeted organ treatment be the best principle for overall management of SLE.

To ensure the best possible clinical outcomes for arthritis patients, it is essential that they be seen early and treated appropriately at the earliest opportunity. Early therapy has proven much more effective than that given late. This issue of Rheumatic Disease Clinics of North America brings the rheumatologist up to date on the latest treatments and interventions in evolving arthritis and established early arthritis. Topics covered include early rheumatoid arthritis, psoriatic arthritis, undifferentiated arthritis, oligoarthritis, osteoarthritis, and others. Imaging modalities are addressed as well as various contemporary treatments including biologics.

This issue is devoted to patient reported outcomes and their impact in the study of rheumatic diseases and the authors will also discuss PROs and vulnerable populations with rheumatic disease; technology, electronic health records and PROs: past, present and future; the promise of PROMIS – a uniform approach to PROs across rheumatic diseases, quality measures and PROs and how they relate and the importance of PROs in delivering quality care in the rheumatic diseases, and many more exciting articles.

This issue of Physician Assistant Clinics, guest edited by Benjamin Smith, is devoted to Rheumatology. Articles in this issue include: Immunology Basics of Rheumatic Disease, The Approach to the Patient with Rheumatic Disease, Osteoarthritis, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Gout and other Cyrstal Arthritides, Fibromyalgia, Inflammatory Myopathies, Vasculitis, Osteoporosis Diagnosis and Management, Axial Spondyloarthritis and Ankylosing Spondylitis, Psoriatic Arthritis, Systemic Sclerosis, Pediatric Rheumatology, Pediatric Rheumatology Pt. II, and more.

Guest edited by Dr. Brian Mandell, this issue of Medical Clinics of North America will cover several key areas of interest related to Rheumatology. This issue is one of six selected each year by our series Consulting Editor, Dr. Jack Ende. Articles in this issue include but are not limited to: Vaccinations in Patients with Rheumatic Disease: Consider Disease and Therapy, Rheumatic Complications of Immune Checkpoint Inhibitors, Managing the Cardiovascular Risk in Patients with Rheumatic Disease, Statin associated myalgias and muscle injury – recognizing and managing both while still lowering the low-density lipoprotein, Perioperative Management of Rheumatic Disease and Therapies, Fibromyalgia: Recognition and Management in the Primary Care Office, Management and Cure of Gouty Arthritis, Update on the Treatment of Giant Cell Arteritis and Polymyalgia Rheumatica, Suspecting and Diagnosing the Patient with Spondyloarthritis and What to Expect from Therapy, Pregnancy and Management in Women with Rheumatoid Arthritis, Systemic Lupus Erythematosus and Obstetrical Antiphospholipid Syndrome, Rheumatoid Arthritis: Early Diagnosis and Treatment, Management of Knee Osteoarthritis: What Internists Need to Know, Antinuclear antibody (ANA) testing for the diagnosis of Systemic Lupus Erythematosus (SLE), and more.

In this first-of-its-kind issue of Rheumatic Disease Clinics, guest editor Dr. Bryant R. England brings his considerable expertise to the topic of Environmental Triggers for Rheumatic Diseases. In practical, state-of-the-art articles, top experts examine the connection between some of the most commonly seen rheumatic disease and environmental triggers for the disease. Contains 13 practice-oriented topics including inhalant and mucosal-related environmental risks for rheumatoid arthritis; lifestyle, hormonal, and microbial-related environmental risks for rheumatoid arthritis; environmental risks for systemic lupus erythematosus; environmental risks for osteoarthritis; targeting environmental risks to prevent rheumatic diseases; and more. Provides in-depth clinical reviews on environmental triggers for rheumatic diseases, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.